Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Philadelphia, Pennsylvania
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Clinical Trials in Philadelphia, Pennsylvania
1 recruiting
Philadelphia, Pennsylvania
Showing
1–1
of
1
trials
Recruiting
Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
Recurrent B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Refractory B Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
84 enrolled
274 locations
NCT03739814
Feedback